Most clinical trials on the efficacy of GLP-1 RAs found a reduced systolic BP, and this beneficial effect was somewhat more apparent in studies of liraglutide and exenatide (Table 2)
Specifically, KLOW adds one compound to the GLOW triple-blend: KPV, a tripeptide derived from the C-terminal of alpha-melanocyte-stimulating hormone that introduces melanocortin receptor-mediated anti-inflammatory signaling into the stack
While it is not a magic pill for weight loss on its own, it is a critical component of the bodys natural metabolic machinery
GLP1 receptor agonists offer a therapeutic breakthrough by mimicking the glucagonlike peptide1 hormone, boosting insulin secretion and suppressing glucagon release, thereby enhancing glycemic control
doi: 10.1016/j.freeradbiomed.2020.08.005 79 MedaCDolceAVegetoEMaggiADella TorreS
These added health benefits make it an attractive option for individuals with obesity-related health issues